A detailed history of Ninety One Uk LTD transactions in Moderna, Inc. stock. As of the latest transaction made, Ninety One Uk LTD holds 91,877 shares of MRNA stock, worth $6.7 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
91,877
Holding current value
$6.7 Million
% of portfolio
0.03%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

BUY
$101.21 - $166.61 $9.3 Million - $15.3 Million
91,877 New
91,877 $10.9 Million
Q2 2022

Aug 15, 2022

SELL
$117.13 - $176.59 $6.77 Million - $10.2 Million
-57,757 Closed
0 $0
Q1 2022

May 26, 2022

BUY
$126.46 - $235.05 $2.95 Million - $5.49 Million
23,344 Added 67.83%
57,757 $9.95 Million
Q4 2021

Feb 11, 2022

SELL
$225.82 - $368.51 $2.17 Million - $3.55 Million
-9,623 Reduced 21.85%
34,413 $8.74 Million
Q3 2021

Nov 02, 2021

SELL
$221.9 - $484.47 $6.68 Million - $14.6 Million
-30,089 Reduced 40.59%
44,036 $16.9 Million
Q2 2021

Aug 12, 2021

BUY
$129.91 - $234.98 $9.63 Million - $17.4 Million
74,125 New
74,125 $17.4 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $28.5B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Ninety One Uk LTD Portfolio

Follow Ninety One Uk LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ninety One Uk LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ninety One Uk LTD with notifications on news.